NCT01374880

Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: Institut National de la Santé Et de la Recherche Médicale, France · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this work is to investigate and then to sequence new biomarkers in the plasma of patients presenting with dyspnea secondary or not to heart failure, and study their diagnostic and prognostic value.

Detailed description

Plasma samples for patients with dyspnea, edema, with or without heart failure; ambulatory or admitted for cardiac decompensation (even with cardiac shock and LVAD) ; or entering a cardiac rehabilitation program, will be prospectively collected. The objective of this work is to investigate and then to sequence new proteins in the plasma of these patients for diagnostic and prognostic purpose.

Conditions

• Heart Failure
• Dyspnea
• Pulmonary Disease

Timeline

• Start date: 2009-06-01
• Primary completion: 2013-09-01
• Completion: 2014-01-01
• First posted: 2011-06-16
• Last updated: 2013-08-14

Locations

1 site across 1 country: France